(Q41526192)

2 October 2017

1 reference

title

Management of early diabetic nephropathy (English)

1 reference

2 October 2017

Molitch ME

1

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

American Journal of Medicine

2 October 2017

published in

1 reference

2 October 2017

volume

102

1 reference

2 October 2017

issue

4

1 reference

2 October 2017

page(s)

392-398

1 reference

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

The changing natural history of nephropathy in type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Unchanged incidence of diabetic nephropathy in IDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Diabetic nephropathy in type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. American Diabetes Association and the National Kidney Foundation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney F

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Prevention of diabetic renal disease with special reference to microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Incipient nephropathy in type 1 (insulin-dependent) diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Predicting diabetic nephropathy in insulin-dependent patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Prospective study of microalbuminuria as predictor of mortality in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Albumin excretion and vascular deaths in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Standards of medical care for patients with diabetes mellitus. American Diabetes Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Single-void urine samples can be used to estimate quantitative microalbuminuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Treatment of hypertension in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Hemodynamically mediated glomerular injury and the progressive nature of kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Mechanisms of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

ACE inhibitors and diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Converting-enzyme inhibitors in the treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Angiotensin receptor antagonists: focus on losartan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Antihypertensive therapy for patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Low-protein diets in renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

Nutrition principles for the management of diabetes and related complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900118-6

10.1016/S0002-9343(97)00118-6

7 January 2021

Identifiers

DOI

1 reference

2 October 2017

1 reference